MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial
Conditions: Renal Cell Carcinoma; Stage I Renal Cell Cancer AJCC v8; Stage II Renal Cell Cancer AJCC v8 Interventions: Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration; Radiation: Stereotactic Body Radiation Therapy Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Radiation Therapy | Research | Urology & Nephrology